This inventor holds 10 USPTO granted patents, plus 1 CIPO patent. Top assignees: Lupin, Inc., Symbiomix Therapeutics, LLC. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: Celebrating the Innovations of Helen S. Pentikis
Introduction
Helen S. Pentikis, an accomplished inventor based in Timonium, Maryland, has made remarkable contributions in the field of pharmaceutical formulations. With a total of 10 patents to her name, her innovations primarily focus on treatments for bacterial vaginosis and sexually transmitted infections, showcasing her dedication to advancing healthcare solutions.
Latest Patents
Among her latest patents is a significant formulation of secnidazole, specifically designed for the treatment of bacterial vaginosis. This invention involves embodiments aimed at providing effective secnidazole formulations that enhance the treatment of this common condition. Additionally, she has also developed a method targeted at treating sexually transmitted infections, which requires administering a therapeutically effective amount of secnidazole in a specialized microgranule formulation. This microgranule population demonstrates a carefully measured volume-weighted particle size distribution, indicating her meticulous approach to pharmaceutical innovation.
Career Highlights
Throughout her career, Helen has had the opportunity to work with notable organizations, including Lupin, Inc. and Symbiomix Therapeutics, LLC. These positions have allowed her to apply her expertise in drug formulation, leading to her successful patent applications and contributing to significant advancements in the pharmaceutical field.
Collaborations
Helen has collaborated with esteemed colleagues, including David Palling and Carol J. Braun. These partnerships have been instrumental in her research and development efforts, facilitating the creation of effective pharmaceutical solutions that address critical health issues.
Conclusion
Helen S. Pentikis exemplifies the spirit of innovation in the pharmaceutical industry. Her dedication to developing treatments that improve patient outcomes underscores the importance of inventors in advancing healthcare. With her extensive patent portfolio and impactful collaborations, Helen continues to pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile